Table 7.
Univariate and multivariate analysis of the six genes in relation to OS among the 33 breast cancer samples from the independent cohort (Centre Léon Bérard, Lyon, France)
Genes | Univariate (n = 33) | Multivariate (n = 33) | ||||
HR | 95% CI | Pa | HR | 95% CI | Pa | |
ESR1 | 0.09 | 0.02 to 0.38 | <10-4 | 0.17 | 0.03 to 0.86 | 0.032 |
FOS | 0.12 | 0.03 to 0.42 | <10-4 | 0.22 | 0.06 to 1.00 | 0.049 |
BCL2 | 0.07 | 0.01 to 0.31 | <10-4 | NS(2)b | ||
SNCG | 0.24 | 0.08 to 0.75 | 0.008 | NS(3) | ||
IGFBP4 | 0.34 | 0.12 to 0.98 | 0.038 | NS(1) | ||
MET | 1.08 | 0.40 to 2.88 | NS | NDc | ND | ND |
aP value was considered significant when P < 0.05. bNS(i), order in which the variable was deleted from the model. cND indicates 'not done'; multivariate analysis was done using the variables found to be significant in univariate analysis. CI, confidence interval; HR, hazard ratio; NS, not significant; OS, overall survival.